ReproCELL Incorporated
JPX: 4978.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chikafumi Yokoyama
- Employees
- 96
- Headquarters
- Yokohama, Japan
- IPO year
- 2013
- Market cap
- ¥16.5B
- Website
- https://www.reprocell.com
Loading 4978…
Loading profile data…Frequently asked questions about 4978
What does ReproCELL Incorporated (4978.T) do?
ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; different...
Where does 4978.T trade?
ReproCELL Incorporated (4978.T) trades on the Tokyo Stock Exchange.
What sector is 4978.T in?
ReproCELL Incorporated (4978.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ReproCELL Incorporated?
Chikafumi Yokoyama is the chief executive officer of ReproCELL Incorporated (4978.T).
Where is ReproCELL Incorporated headquartered?
ReproCELL Incorporated is headquartered in Japan.
Does 4978.T pay a dividend?
ReproCELL Incorporated (4978.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4978.T go public?
ReproCELL Incorporated (4978.T) completed its initial public offering in 2013.